Clinical trial
VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic…
NCT00407485 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00407485 |
|---|---|
| Title | VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium |
| Official title | A Phase II Study of VEGF Trap (NSC 724770) in Patients With Recurrent or Metastatic Transitional Carcinoma of the Urothelium |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adenocarcinoma of the Bladder, Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Squamous Cell Carcinoma of the Bladder, Stage III Bladder Cancer, Stage III Urethral Cancer and 3 more |
| Intervention type | Biological, Other |
| Interventions | ziv-aflibercept, pharmacological study |
| Enrollment | 22 |
| Start date | Nov 1, 2006 |
| Primary completion | Apr 1, 2010 |
| Completion | Apr 1, 2014 |
| First posted | Dec 5, 2006 |
| Last update posted | Oct 20, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: